vaccines

Pages Tagged with "Vaccines"

New preclinical data show broad immune response to City of Hope-developed COVID-19 vaccine
  Don J. Diamond, Ph.D. COH04S1, a City of Hope-developed COVID-19 investigational vaccine, stimulated broad-spectrum protective immunity against SARS-CoV-2 variants in new preclinical research due to its inclusion of both...
City of Hope physicians/scientists lead multiple, innovative COVID-19 research projects
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   Chimeric antigen receptor (CAR)-NK cell therapy to treat the virus is one of more than two dozen COVID-19 research projects underway   DUARTE, Calif...
City of Hope scientists delving into COVID-19 research
As City of Hope’s research to find better treatments for cancer and diabetes continues during the COVID-19 pandemic, the institution’s renowned physician-scientists are also using their expertise to attack the deadly...
Phase 2 Trial Opens for City of Hope's Novel COVID-19 Vaccine
City of Hope is now enrolling patients in a Phase 2 clinical trial of its COH04S1 vaccine, which is the first to study the safety and effectiveness of an investigational...
Researcher developing vaccine for Kaposi sarcoma
“It’s not HIV that kills you, it’s the co-infections that do,” said Javier Gordon Ogembo, Ph.D., associate professor in the Department of Immuno-Oncology at City of Hope.   Among the deadliest...
City of Hope Enters Commercial License Agreement to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   DUARTE, Calif. — ProBioGen AG has announced a commercial product license agreement with City of Hope®, a world-renowned independent research and treatment center for...
City of Hope now enrolling patients for Phase 1 type 1 diabetes investigational vaccine trial
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   The investigational vaccine is the first-of-its-kind for type 1 diabetes to be tested in the United States and showed positive results in an early...
City of Hope COVID-19 vaccine shows effectiveness in Phase 1 trial
A COVID-19 investigational vaccine developed by City of Hope scientists and now licensed to GeoVax Labs Inc. produced a robust neutralizing antibody and T cell (an immune cell) response against...
City of Hope initiates phase 1 clinical trial to test its first SARS-CoV-2 investigational vaccine
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   •    The vaccine strategy used to generate this candidate has a record of safety and efficacy, rapid immune response and lasting protection   •  ...
Your immune system in an emergency: Q&A with an immunologist
Saul Priceman, Ph.D. At the moment, there is no vaccine and no medication that has been proven to target COVID-19. All we have right now is the body’s own frontline...